• AAPL 169.3
  • TSLA 168.29
  • AMZN 179.62
  • MSFT 406.32
  • INTC 31.88
  • EURUSD 1.0699
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. MU /
  3. 5VB.MU

Vaccibody AS (5VB MU) stock market data APIs

€1.11 0(0%) as of April 26, 2024

Vaccibody AS Financial Data Overview

1.11
1.11
-
1.11
1.11
1.108-2.596
2 200 M
0
0
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: '5VB',
Type: 'Common Stock',
Name: 'Vaccibody AS',
Exchange: 'MU',
CurrencyCode: 'EUR',
CurrencyName: 'Euro',
CurrencySymbol: '€',
CountryName: 'Germany',
CountryISO: 'DE',
OpenFigi: NULL,
ISIN: 'NO0010714785',
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: NULL,
Industry: NULL,
}

Vaccibody AS Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA 0
  • Earnings Per Share
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Vaccibody AS Earnings via APIs

  • Latest Release NaN
  • EPS/Forecast NaN

Get Vaccibody AS End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Vaccibody AS latest news via APIs

Nykode Therapeutics Initiates Phase 2 Trial of VB10.16 in Second Line HPV16-Positive Cervical Cancer

Nykode Therapeutics ASA OSLO, Norway, April 19, 2024 (GLOBE NEWSWIRE) -- Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of ...

Nykode Therapeutics - Quarterly report Q3 2023

Nykode Therapeutics ASA OSLO, Norway, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of n...
Do you have any questions?
support@eodhistoricaldata.com